This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...

Costa Mesa, California - February 20, 2026 - PRESSADVANTAGE - Zenapet, a pet wellness company focused on nutritional ...

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo ® for intravenous administration in the treatment of moderate to severe SLE. If approved, a ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

A Consumer Information Guide to Nail Refresh's Tea Tree Oil, Oregano Oil, and Multi-Botanical Essential Oil Blend for Topical Toenail Care ...

Anifrolumab, a type I interferon receptor antagonist, is already approved as an intravenous (IV) therapy for SLE. The TULIP-SC trial was designed to evaluate whether a weekly subcutaneous (SC) ...

A 67-year-old Siliguri resident, after prostate cancer treatment, embraced Ayurveda and yoga for recovery. Within months, his ...

Large Danish cohort study reassures, with some women appearing to have a survival benefit ...

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient in Dramamine.Meclizine was the top-prescribed antiemetic/a ...

Kidney health has become an increasing concern in modern times, with rising cases of elevated creatinine levels and chronic ...

The original ruling did not permanently bar the comptroller from auditing the events of October 7, but temporarily froze work on eight defined “core” audits while ...